Medscape reports that a large cohort study, published online July 22 in Depression and Anxiety, “of Israeli patients with cancer found that antidepressant adherence above 50% was associated with one quarter less mortality over four years compared with adherence below 20%.” Investigators “reported that any adherence above 20% was linked to increased survival over the four years of the study.”
Related Links:
— “Cancer Survival Linked to Antidepressant Adherence, “Helen Leask, Medscape, August 05, 2019